SIRIO PHARMA CO. LTD.

Company Snapshot

Founded: 1993
Entity Type: Public
Employees: 2,776
Region: America
Revenue: $585.2 Millions
Revenue Year: 2024
Headquarter: Guangdong, China
Key Geographics: China, America, Europe, Other areas
Corporate Address: No.83 Taishan Rd, Shantou, Guangdong, China Tel. +86-754-889-24286 www.siriopharma.com

Company Overview

Sirio consistently strives to exceed the highest standards of quality in product development. It offers adaptable, efficient solutions and collaborates closely with clients, making them reliable partners. It is a globally integrated contract manufacturer that offers comprehensive dietary supplement solutions, earning certification by 26 internationally recognized standards. As the industry leader in quality, service, and innovation, Sirio caters to clients worldwide.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

SIRIO PHARMA CO. LTD. In Reports

Softgel Capsules: Global Markets

BCC Research Market Analyst says global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029 at a CAGR of 7.7%.

Softgel Capsules: Global Markets

BCC Market Research Report says softgel capsules should grow from over $4.4 billion in 2020 to $5.9 billion by 2025 at a compound annual growth rate of 5.7%.

Company's Business Segments

  • Product : Softgels, Gummies, Liquids, Tablets, Powders, Hard capsules
  • Service : End-to-End Solutions, Research Competence, Support, Others

Applications/End User Industries

  • Healthcare
  • Pharmaceuticals
  • Retail and E-commerce
  • Consumer Goods
  • Wellness and Nutrition
AI Sentiment